Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Analysis
  • Published:

Quietly rationalizing drug discovery

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bialy, H. 1990. Can antibodies to IgE-act as anti-allergies? Bio/Technology 8: 96.

    Google Scholar 

  2. Chang, T.W., et al. 1990. Monoclonal antibodies specific for human IgE-producing B cells: A potential therapeutic for IgE-mediated allergic diseases. Bio/Technology 8: 122–126.

    CAS  Google Scholar 

  3. Presta, L.G., et al. 1993. Humanization of an antibody directed against IgE. J. Immimol. 151: 2623–2632.

    CAS  Google Scholar 

  4. Davis, F.M., et al. 1991. Monoclonal antibodies that bind to membrane-bound IgE but not secreted IgE. Bio/Technology 9: 53–56.

    CAS  PubMed  Google Scholar 

  5. Peng, C., et al. 1992. A new isoform of human membrane-bound IgE. J. Immunol. 148: 129–136.

    CAS  PubMed  Google Scholar 

  6. Zhang, K., et al. 1992. Two unusual forms of human immunoglobulin E encoded by alternative RNA splicing of ɛ heavy chain membrane exons. J. Exp. Med. 176: 233–243.

    Article  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bialy, H. Quietly rationalizing drug discovery. Nat Biotechnol 11, 1516–1517 (1993). https://doi.org/10.1038/nbt1293-1516

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1293-1516

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing